Simple Summary Hepatocellular carcinoma (HCC) represents one of the main indications
for liver transplantation. Over recent years, immune checkpoint inhibitor (ICI) therapy has …

As the most common non-Hodgkin lymphoma subtype, diffuse large B-cell lymphoma
(DLBCL) incidence patterns generally parallel that for NHL overall. Globally, DLBCL …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

Since the first approval for immune checkpoint inhibitors (ICIs) for the treatment of cutaneous
melanoma more than a decade ago, immunotherapy has completely transformed the …

Background Diminished immune defense plays an important role in cancer development.
Cancer risk in immunocompromised patients may differ. Identifying individuals with elevated …

Purpose of review Extragonadal germ cell tumors (EGCTs) are relatively rare tumors,
accounting for 1%–5% of all GCTs. In this review, we summarize the current research …

A relationship between lung transplant success and many features of recipients'/donors has
long been studied. However, modeling a robust model of a potential impact on organ …

Aim This study aimed to systematically characterize transplant rejection after immune
checkpoint inhibitors (ICIs) initiation in solid organ transplant recipients (SOTRs). Methods …

Despite significant advances in the screening, diagnosis, and treatment of colorectal cancer
(CRC) immune checkpoint inhibitors (ICIs) continue to have limited utility outside of …

Simple Summary Lung transplant recipients are at high risk of malignancies. Despite the
continuous improvements in lung transplant outcomes over time, limited knowledge exists …